Merck Says Covid Drug Cut Hospitalization, Deaths by Half
https://www.bloomberg.com/news/articles/2021-10-01/merck-says-covid-antiviral-cut-hospitalization-deaths-by-half

Merck & Co Inc.’s Covid-19 antiviral pill molnupiravir reduced the risk of hospitalization or death by 50% in an interim analysis of a late-stage trial, findings that could give doctors another potent virus-fighting tool.